MedDataX Logo

Pneumatic Sleeves and Congestive Heart Failure

NCT ID: NCT01691417

Last Updated: 2012-09-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Based on the reversal of the adverse cardiovascular parameters during Laproscopic Surgery and its influence on cardiac activity in healthy subjects, the investigators expect to improved cardiac function in patients suffering from congestive heart failure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Congestive Heart Failure

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pneumatic Sleeves

Group Type EXPERIMENTAL

Intermittent Sequntial Pnumatic Compression Leg Sleeves

Intervention Type DEVICE

Congestive Heart Failure Patients

Group Type EXPERIMENTAL

Intermittent Sequntial Pnumatic Compression Leg Sleeves

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intermittent Sequntial Pnumatic Compression Leg Sleeves

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* CHF (as clinically evaluated and asessed by TTE)
* Gave informed consent
* NYHA Class II-III
* LVEF equal or less than 40%

Exclusion Criteria

* Patients who could not sign informed consent
* NYHA Class IV
* Oxygen saturation less than 90% under room air
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Western Galilee Hospital-Nahariya

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Western Galilee Hospital

Nahariya, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Sleeves-Bickel

Identifier Type: -

Identifier Source: org_study_id